Łuczkowska, K.; Taryma-Leśniak, O.; Bińkowski, J.; Sokołowska, K.E.; Strapagiel, D.; Jarczak, J.; Paczkowska, E.; Machaliński, B.; Wojdacz, T.K.
Long-Term Treatment with Bortezomib Induces Specific Methylation Changes in Differentiated Neuronal Cells. Cancers 2022, 14, 3402.
https://doi.org/10.3390/cancers14143402
AMA Style
Łuczkowska K, Taryma-Leśniak O, Bińkowski J, Sokołowska KE, Strapagiel D, Jarczak J, Paczkowska E, Machaliński B, Wojdacz TK.
Long-Term Treatment with Bortezomib Induces Specific Methylation Changes in Differentiated Neuronal Cells. Cancers. 2022; 14(14):3402.
https://doi.org/10.3390/cancers14143402
Chicago/Turabian Style
Łuczkowska, Karolina, Olga Taryma-Leśniak, Jan Bińkowski, Katarzyna E. Sokołowska, Dominik Strapagiel, Justyna Jarczak, Edyta Paczkowska, Bogusław Machaliński, and Tomasz K. Wojdacz.
2022. "Long-Term Treatment with Bortezomib Induces Specific Methylation Changes in Differentiated Neuronal Cells" Cancers 14, no. 14: 3402.
https://doi.org/10.3390/cancers14143402
APA Style
Łuczkowska, K., Taryma-Leśniak, O., Bińkowski, J., Sokołowska, K. E., Strapagiel, D., Jarczak, J., Paczkowska, E., Machaliński, B., & Wojdacz, T. K.
(2022). Long-Term Treatment with Bortezomib Induces Specific Methylation Changes in Differentiated Neuronal Cells. Cancers, 14(14), 3402.
https://doi.org/10.3390/cancers14143402